Closing Bell: Fennec Pharmaceuticals Inc down on Tuesday (FRX)

Today in trading, Fennec Pharmaceuticals Inc stock opened at $7.95 and closed at $7.95. prices ranged from a low of $7.95 to a high of $7.95.

Shares eased -0.38% from the previous day's close of $7.98.

Today across North America, the TSX Composite closed -0.45% at 21880.95, the S&P 500 closed -0.77% at 5199.50, the Dow Jones Industrial Average closed -0.60% at 38763.45 and the Nasdaq Composite closed 1.03% at 16366.85.

Fennec Pharmaceuticals Inc traded under FRX on the Toronto Stock Exchange (TSX).

A total of 114 shares was traded during the last trading day, with total trades of 3, while having an average volume of 368 over the last 5-days.

The TSX market on the whole today saw 1,858 price advancers against 3,319 declines and 108 unchanged.

During the prior 52 weeks, FRX.TO has traded as high as $15.43 (December 28,2023) and low as $7.80 (July 05,2024). Moreover, the shares have shrunken -25.21 percent in the last 12 months, while this year, they have shrunken -47.56%.

Following today's trading, Fennec Pharmaceuticals Inc has a market capitalization of $217.21 million on a float of 27,322 shares outstanding. Its annual EPS is $0.04.

Fennec Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Research Triangle Park, USA.

Currently, Fennec Pharmaceuticals Inc's consensus rating is "Strong Buy" based on 6 analysts according to Zacks. Currently, there are 6 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..